Altria Oral Tobacco Margins Hit 69%: Pricing Power or Mix Shift?
Werte in diesem Artikel
Altria Group, Inc.’s (MO) oral tobacco business delivered a standout margin performance in the third quarter of 2025, with adjusted operating company income margins rising 2.4 percentage points to 69.2%. That lift came even as segment revenues declined and overall shipment volumes fell 9.6%, reflecting retail share pressure, calendar timing and trade inventory dynamics. The key question is what drove this margin expansion: pricing power or mix?The data points more to pricing decisions than product mix. Altria increased prices, which helped offset the impact of selling more on!, its oral nicotine pouch brand. While many brands in the pouch category lowered prices through heavy promotions, Altria exhibited strong pricing discipline, with on!'s average retail price actually increasing slightly.Management noted that the quarter included a “mix change,” with a higher percentage of on! relative to moist smokeless tobacco. Despite that shift, the segment still delivered margin expansion, supported by higher pricing and lower costs. In other words, the margin lift came from execution, pricing discipline and cost control, rather than from the mix of products alone.Overall, Altria’s 69% oral tobacco margin reflects effective pricing and cost control in a competitive environment. While the continued shift toward pouches bears watching, the quarter demonstrated that the company is currently able to sustain profitability through disciplined execution.Where PM and TPB Stand Next to Altria in Oral NicotinePhilip Morris International Inc. (PM) reported strong momentum in its modern oral portfolio in the third quarter of 2025, driven primarily by ZYN’s continued volume growth. The company noted that retail share gains were supported by distribution expansion and increased brand visibility. At the same time, Philip Morris highlighted ongoing investments in capacity and commercialization, which remain necessary to support category growth. These efforts helped reinforce Philip Morris’ positioning in the fast-growing oral nicotine segment.Turning Point Brands, Inc. (TPB) continued to scale its modern oral portfolio, reporting nearly eightfold year-over-year growth in modern oral revenues to $30.1 million in the second quarter of 2025. The expansion was driven by the FRE pouch line and supported by stronger contributions from the Stoker’s segment. Despite elevated marketing and distribution investments, Turning Point Brands maintained cost discipline and margin focus. As a result, Turning Point Brands remains positioned for steady category participation and improving profitability.Altria’s Price Performance, Valuation & EstimatesShares of Altria have lost 12.5% in the past month compared with the industry’s decline of 5.7%.Image Source: Zacks Investment ResearchFrom a valuation standpoint, MO trades at a forward price-to-earnings ratio of 10.33X, down from the industry’s average of 13.44X.Image Source: Zacks Investment ResearchThe Zacks Consensus Estimate for MO’s 2025 and 2026 earnings implies year-over-year growth of 6.1% and 2.5%, respectively.Image Source: Zacks Investment ResearchAltria currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Zacks Names #1 Semiconductor StockThis under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Altria Group, Inc. (MO): Free Stock Analysis Report Philip Morris International Inc. (PM): Free Stock Analysis Report Turning Point Brands, Inc. (TPB): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Altria und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Altria
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Altria
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: Zacks
Nachrichten zu Altria Inc.
Analysen zu Altria Inc.
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.04.2020 | Altria Hold | Jefferies & Company Inc. | |
| 12.07.2019 | Altria buy | Goldman Sachs Group Inc. | |
| 31.07.2017 | Altria Neutral | UBS AG | |
| 31.07.2017 | Altria Buy | Stifel, Nicolaus & Co., Inc. | |
| 31.07.2017 | Altria Sector Perform | RBC Capital Markets |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.07.2019 | Altria buy | Goldman Sachs Group Inc. | |
| 31.07.2017 | Altria Buy | Stifel, Nicolaus & Co., Inc. | |
| 27.06.2016 | Altria Group Buy | Stifel, Nicolaus & Co., Inc. | |
| 02.02.2015 | Altria Group Buy | Stifel, Nicolaus & Co., Inc. | |
| 31.10.2014 | Altria Group Buy | Stifel, Nicolaus & Co., Inc. |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.04.2020 | Altria Hold | Jefferies & Company Inc. | |
| 31.07.2017 | Altria Neutral | UBS AG | |
| 31.07.2017 | Altria Sector Perform | RBC Capital Markets | |
| 09.08.2012 | Altria Group neutral | Citigroup Corp. | |
| 26.07.2012 | Altria Group neutral | UBS AG |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.03.2017 | Altria Group Underperform | RBC Capital Markets | |
| 27.04.2005 | Update UST Inc.: Underperform | Goldman Sachs | |
| 27.04.2005 | UST: Underweight | JP Morgan | |
| 24.01.2005 | UST: Underweight | JP Morgan |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Altria Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen